A detailed history of Berkeley Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 17,693 shares of MRK stock, worth $1.7 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
17,693
Previous 4,854 264.5%
Holding current value
$1.7 Million
Previous $600,000 234.83%
% of portfolio
0.58%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $1.43 Million - $1.66 Million
12,839 Added 264.5%
17,693 $2.01 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $61,776 - $66,347
499 Added 11.46%
4,854 $600,000
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $1.34 Million - $1.56 Million
-11,811 Reduced 73.06%
4,355 $574,000
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $16,930 - $18,424
-169 Reduced 1.03%
16,166 $1.76 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $20,692 - $22,980
201 Added 1.25%
16,335 $1.68 Million
Q2 2023

Aug 03, 2023

BUY
$108.61 - $118.38 $160,199 - $174,610
1,475 Added 10.06%
16,134 $1.86 Million
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $2,161 - $2,412
21 Added 0.14%
14,659 $1.56 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $21,335 - $27,354
-244 Reduced 1.64%
14,638 $1.62 Million
Q3 2022

Nov 04, 2022

BUY
$84.53 - $94.96 $272,947 - $306,625
3,229 Added 27.71%
14,882 $1.28 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $137,174 - $155,493
1,643 Added 16.41%
11,653 $1.06 Million
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $403,349 - $452,128
5,487 Added 121.31%
10,010 $821,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $97,361 - $121,957
1,347 Added 42.41%
4,523 $347,000
Q3 2021

Nov 04, 2021

BUY
$71.68 - $78.83 $227,655 - $250,364
3,176 New
3,176 $239,000
Q1 2021

May 04, 2021

SELL
$68.86 - $81.11 $213,397 - $251,359
-3,099 Closed
0 $0
Q4 2020

Jan 28, 2021

SELL
$71.77 - $79.65 $48,372 - $53,684
-674 Reduced 17.86%
3,099 $253,000
Q3 2020

Nov 03, 2020

BUY
$73.18 - $82.95 $276,108 - $312,970
3,773 New
3,773 $313,000
Q2 2020

Jul 30, 2020

SELL
$70.42 - $80.13 $479,771 - $545,925
-6,813 Closed
0 $0
Q1 2020

Apr 21, 2020

BUY
$63.36 - $87.82 $133,943 - $185,651
2,114 Added 44.99%
6,813 $524,000
Q4 2019

Jan 24, 2020

SELL
$77.58 - $87.54 $41,350 - $46,658
-533 Reduced 10.19%
4,699 $427,000
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $72,276 - $78,783
950 Added 22.19%
5,232 $440,000
Q2 2019

Aug 08, 2019

BUY
$69.84 - $81.59 $24,444 - $28,556
350 Added 8.9%
4,282 $359,000
Q1 2019

Apr 30, 2019

SELL
$69.58 - $79.36 $2,713 - $3,095
-39 Reduced 0.98%
3,932 $327,000
Q4 2018

Jan 28, 2019

SELL
$65.24 - $75.71 $15,200 - $17,640
-233 Reduced 5.54%
3,971 $303,000
Q3 2018

Oct 30, 2018

BUY
$57.69 - $67.84 $3,288 - $3,866
57 Added 1.37%
4,204 $298,000
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $202,506 - $237,924
-3,984 Reduced 49.0%
4,147 $251,000
Q1 2018

Apr 27, 2018

SELL
$50.96 - $59.23 $55,852 - $64,916
-1,096 Reduced 11.88%
8,131 $442,000
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $280,967 - $335,506
5,443 Added 143.84%
9,227 $519,000
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $222,007 - $238,883
3,784
3,784 $242,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Berkeley Capital Partners, LLC Portfolio

Follow Berkeley Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.